IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial Read More
AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25% Read More
AstraZeneca partners with Regeneron to research obesity treatment Read More
AstraZeneca drug Ultomiris recommended in EU for rare blood disorder Read More
TOP NEWS: AstraZeneca vaccine effective after one dose, study shows Read More
UK earnings, trading statements calendar - next 7 days Read More
EXECUTIVE CHANGES: Nuformix responds to "frustration" as CEO departs Read More
AstraZeneca completes buy of rare diseases specialist Alexion Read More
CORRECT (Jul 19): Astra lung cancer treatment Imfinzi backed in China Read More
TOP NEWS: AstraZeneca lung cancer treatment Imfinzi approved in China Read More
LONDON MARKET PRE-OPEN: Synthomer lifts outlook on strong momentum Read More
TOP NEWS: AstraZeneca kidney disease treatment rejected in US FDA vote Read More
LONDON MARKET PRE-OPEN: Rio Tinto warns on disruption; DCC trades well Read More
UPDATE: London transport mask policy seen "in line with" UK government Read More
TOP NEWS: AstraZeneca's Alexion takeover gets UK watchdog clearance Read More
PRESS: Popular Spanish holiday islands to return to UK amber list Read More
LONDON MARKET PRE-OPEN: Barrat and Dunelm report strong demand Read More
TRADING UPDATES: Smiths gets Euros sticker boost; Hotel Chocolat grows Read More
Circassia up as Niox concern reports raised revenue, positive earnings Read More
BROKER RATINGS: Morgan Stanley cuts Wizz Air but upgrades easyJet Read More
